Thermo Fisher Scientific provides over 20 years of unparalleled experience in developing and manufacturing viral vector products. We specialize in addressing the complexities of viral vector production for cell and gene therapies, including challenges related to production system selection, product quality optimization, and standardization for a robust CMC approach.
As a leading CDMO, we provide end-to-end viral vector services, encompassing process and analytical development, process validation, clinical and commercial manufacturing, in-process and release testing, and fill-finish services. With a global network of production sites and extensive technical and regulatory expertise, we're committed to helping biopharma companies de-risk and accelerate their therapy’s path to market.